Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01809925 · ClinicalTrials.gov registry record · NA

Study of Psyllium 6.8 g Versus Placebo on Satiety in Healthy Volunteers

A NA study of Hunger, sponsored by Procter and Gamble.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT01809925 is a NA study of Hunger that has completed, run by Procter and Gamble. The registered enrollment target is 45 participants, below the 80-participant average among 7 other Hunger trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01809925, a NA study of Hunger, has completed, sponsored by Procter and Gamble.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

This is a randomized, double-blind, placebo-controlled, 2-treatment, 3-period crossover design study to evaluate the effects of psyllium 6.8 g provided as sugarfree Metamucil fiber supplement powder dissolved in water versus placebo on satiety measures in healthy volunteers. This study will be conducted at a single study site.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT placebo
  • DIETARY_SUPPLEMENT psyllium fiber 6.8g

Study Locations (1)

Ohio

  • Study Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2013-03
Est. Completion 2013-04
Phase NA

Sponsor

Procter and Gamble

70 total trials

What the Registry Record Tells You About NCT01809925

The ClinicalTrials.gov registry entry for NCT01809925 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80-participant average among 7 other Hunger trials with a reported enrollment target (44% lower). The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hunger appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT01809925 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01809925 about?

NCT01809925 is a clinical study titled "Study of Psyllium 6.8 g Versus Placebo on Satiety in Healthy Volunteers". This is a randomized, double-blind, placebo-controlled, 2-treatment, 3-period crossover design study to evaluate the effects of psyllium 6.8 g provided as sugarfree Metamucil fiber supplement powder dissolved in water versus placebo on satiety measures in healthy volunteers. This study will be condu...

What is the current status of trial NCT01809925?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2013-03. Estimated completion is 2013-04.

What conditions does trial NCT01809925 study?

This clinical trial studies the following conditions: Hunger.

What interventions are being tested in trial NCT01809925?

The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), psyllium fiber 6.8g (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01809925?

This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01809925 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hunger

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.